Targeting the Tumor Epigenetic Regulator SETDB1 for Tumor Therapy
Cheng Peng(Shandong First Medical University), Shunqin Zhu(Southwest University), Chang Wen Chen(Hong Kong Polytechnic University), Ni‐Ni Zhou(Southwest University), Jie Lei(Air Force Medical University), Tengjiang Chen(Southwest University)
Cited by 3
Related Papers
Asymmetric organocatalysis: an enabling technology for medicinal chemistry
|Chemical Society Reviews|2021|402
Recent advances in targeting the “undruggable” proteins: from drug discovery to clinical trials
|Signal Transduction and Targeted Therapy|2023|364
Single-cell Stereo-seq reveals induced progenitor cells involved in axolotl brain regeneration
|Science|2022|306
NULISA: a proteomic liquid biopsy platform with attomolar sensitivity and high multiplexing
|Nature Communications|2023|203
An integrated peach genome structural variation map uncovers genes associated with fruit traits
|Genome biology|2020|160